Josh specializes in the chemistry of small and large molecules, intellectual property, as well as leads our efforts in particular disease and technology areas. He also leads RTW’s internship and outreach programs.
Josh has more than a decade of professional experience in the pharmaceutical industry as both a research scientist and manager. Prior to joining RTW, he served as Principal Scientist and Head of Externalization at Schrodinger. Josh has experience in the area of inflammation and autoimmune disease and served as a key contributor on a number of kinase inhibitor programs still in development. He began his career at Roche as a medicinal chemist working on the team that discovered the drug Elpida (elsulfavirine) for HIV.
As an industry trained scientist there’s nothing more exciting than having the opportunity to work at the cutting edge of drug discovery. It’s even more of an honor to do this with such a talented group of individuals and an inspiration to carry out our work in the name of patients.
Josh received a PhD in Chemistry from University of California, Berkeley and a BS in Chemistry from University of California, Santa Cruz and appears as an author and inventor on over 35 publications and patents. He has worked globally at sites in the US, Switzerland, and India.